MedPath

蓬莱金创药业有限公司

Ownership
-
Established
2002-02-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

脑心舒口服液

Approval Number
国药准字Z22023331
Approval Date
Mar 23, 2021
NMPA

生脉饮

Approval Number
国药准字Z37020031
Approval Date
Mar 8, 2021
NMPA

Oyster Shell Calcium Granules

Product Name
牡蛎碳酸钙颗粒
Approval Number
国药准字H22024920
Approval Date
May 9, 2020
NMPA

养血当归糖浆

Approval Number
国药准字Z37020034
Approval Date
May 9, 2020
NMPA

Naftopidil Dispersible Tablets

Product Name
愈畅
Approval Number
国药准字H20052080
Approval Date
Apr 17, 2020
NMPA

Sertraline Hydrochloride Capsules

Product Name
愈朗
Approval Number
国药准字H20051830
Approval Date
Apr 17, 2020
NMPA

补中益气合剂

Approval Number
国药准字Z37020202
Approval Date
Apr 17, 2020
NMPA

强力枇杷露

Approval Number
国药准字Z37020035
Approval Date
Apr 17, 2020
NMPA

脑乐静

Approval Number
国药准字Z37020038
Approval Date
Aug 10, 2015
NMPA

消炎利胆片

Approval Number
国药准字Z22025382
Approval Date
Apr 24, 2015
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.